Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2008
10/01/2008EP1973549A2 Methods and compositions for administration of iron
10/01/2008EP1496877B1 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
10/01/2008EP1480659B9 Use of zeolithes for reducing the proportion of lactates in human and animal organisms
10/01/2008EP1357936B1 Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
10/01/2008EP1331935B1 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
10/01/2008CN101277965A N-phenyl benzamide derivatives as sirtuin modulators
10/01/2008CN101277963A Benzimidazole derivatives as SIRTUIN modulators
10/01/2008CN101277699A Sustained-release preparation
10/01/2008CN101277693A Use of enoxaparin for performimg percutaneous coronary intervention
10/01/2008CN101275158A Screening preparation for superior enterococcus faecalis and application thereof
10/01/2008CN101275126A Purified high-specific-activity recombinant batroxobin
10/01/2008CN101274931A Preparing process for rupatadine
10/01/2008CN101274929A Thrombin receptor antagonists
10/01/2008CN101274096A Stable Batroxobin medicament composition
10/01/2008CN101274071A Hot drink paste preparation for curing thrombocytopenia in type of internal heat due to yin deficiency
10/01/2008CN101274000A Medicine use of herb aralia elata seem
10/01/2008CN101273997A Formulations of zhenmupian and other medicines and method for preparing the same
10/01/2008CN101273996A Method for purifying blood and blood products
10/01/2008CN101273995A Method for preparing magnetic particles modified by afi-tiazin dyes and application
10/01/2008CN101273787A Pure Chinese medicinal health care black-bone chicken
10/01/2008CN100422332C Expression and export of angiostation and endostatin as immunofusins
10/01/2008CN100421662C Disperese torasemide tablet and its prepn and application
10/01/2008CN100421657C Acidum transamicum sodium chloride injection liquid preparation method
09/2008
09/30/2008US7429647 Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
09/30/2008US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
09/30/2008US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use
09/30/2008US7429568 Antidiabetic agents; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; hyperglycemia, obesity; 3-(6-O-ethoxycarbonyl- beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole
09/30/2008US7429489 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine
09/30/2008US7429377 Therapeutic composition containing a plurality of immobilized proteases
09/30/2008CA2405716C Chemically modified novel erythropoietin stimulating protein compositions and methods
09/30/2008CA2285573C A method for stimulating red blood cell production
09/30/2008CA1341580C Tissue-type plasminogen activator mutants
09/25/2008WO2008115999A1 Biaryl and biheteroaryl compounds useful in treating iron disorders
09/25/2008WO2008114819A1 Novel adenine compound
09/25/2008WO2008114812A1 Jak inhibitor
09/25/2008WO2008114679A1 Bone metabolism ameliorating agent
09/25/2008WO2008113863A2 Nitrosated derivatives of 2,5-dihydroxybenzene compounds
09/25/2008US20080234379 Therapeutic methods employing nitric oxide precursors
09/25/2008US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
09/25/2008US20080234337 Promoting of potassium excretion; alleviating arrhythmia, atrioventricular block, ventricular fibrillation, atrial fibrillation and dyspnoea; e.g., 1 (({3-[((1R,2S,3R)-3-hydroxy-2-{(1E,3S)-3-hydroxy-4-[3-(methoxymethyl)phenyl]but-1-enyl}-5-oxocyclopentyl)sulfanyl]propyl}sulfanyl)acetic acid)
09/25/2008US20080234198 Amino acid sequences having C-terminal extensions or modifications, used as activators of G-protein coupled receptor kinases (VPAC2), for treating non-insulin-dependent or insulin-dependent diabetes; antidiabetic agents
09/25/2008US20080234176 Modified peptides and their uses
09/25/2008US20080233222 Method of Improving Cardiovascular Health
09/25/2008US20080233078 Therapeutic polyesters and polyamides
09/25/2008DE102005060690B4 Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen Salts of clopidogrel with polyanions and their use for the preparation of pharmaceutical formulations
09/25/2008CA2678949A1 Biaryl and biheteroaryl compounds useful in treating iron disorders
09/24/2008EP1972687A1 Polynucleotides and polypeptides of human factor VII gene, SNPs
09/24/2008EP1972339A1 Haemostatic Compositions
09/24/2008EP1971582A1 Macrocyclic factor viia inhibitors useful as anticoagulants
09/24/2008EP1971368A2 Compositions and methods for treating thrombocytopenia
09/24/2008EP1646373B1 Orodispersible pharmaceutical composition of an antithrombotic compound
09/24/2008EP1513520B1 Substituted pyrrolines as kinase inhibitors
09/24/2008EP1232254B1 Process for the production of a reversibly inactive acidified plasmin composition
09/24/2008CN101273128A Platelet aggregation inhibitor composition
09/24/2008CN101270362A Novel serine protease genes related to DPPIV
09/24/2008CN101270152A Peptide medicament series for accelerating medulla hematopoiesis cell proliferation
09/24/2008CN101270151A Peptide medicaments for accelerating medulla hematopoiesis cell proliferation
09/24/2008CN101270072A Right-handed indobufen and use for preparing medicament
09/24/2008CN101270052A Eugenol aspirin ester pharmaceutical compound, preparation and preparing method
09/24/2008CN101269243A Methods and systems for preparing blood products
09/24/2008CN101269216A Oral preparation for reducing brinolase, preparation method and uses thereof
09/24/2008CN101269126A Externally used plaster medicine for treating anemia
09/24/2008CN101269114A Preparation technique for lamiophlomis rotate active component extract and application thereof
09/24/2008CN101269112A Traditional Chinese medicine preparation for qi-benefitting, blood-nourishing, wind-expelling and vein-relaxing and preparation method thereof
09/24/2008CN101269079A Emulsion composition comprising prostaglandin E1
09/24/2008CN101269043A Nicardipine hydrochloride sustained-release dropping pill and preparation method thereof
09/24/2008CN101269031A Ligustrazine phosphoric acid sustained-release dropping pill and preparation method thereof
09/24/2008CN101269027A Atenolol sustained-release dropping pill and preparation method thereof
09/24/2008CN101269021A Puerarin sustained-release dropping pills and preparation method thereof
09/24/2008CN101268848A Dew concentration beverage
09/24/2008CN101268844A Healthcare pheasant Soup and preparing technique
09/24/2008CN101268843A Babaoshan chicken soup and preparing technique
09/24/2008CN101268839A Longan braized young chicken and preparing technique
09/24/2008CN100420698C Process for extracting amygdalin and use thereof
09/24/2008CN100420689C Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant
09/24/2008CN100420682C Separating preparation process of salvianolic acid B
09/24/2008CN100420485C Composition containing active prourokinase, freeze-drying process and freeze-dried preparation thereof
09/24/2008CN100420444C Pennogenic compound liquid molecular dispersible preparation
09/24/2008CN100420437C Tetramethylpyrazine phosphate slow-release micro-pill and its preparing method
09/23/2008US7427632 Factor Xa inhibitors
09/23/2008US7427631 especially as inhibitors of MMP12
09/23/2008US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof
09/23/2008US7427618 e.g. 2-[3-(4-ethynylphenyl)ureido]-N-[4-(3-oxomorpholin-4-yl)phenyl]valeramide; anticoagulant, antitumor factor; thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, claudicatio intermittens, or migraine
09/23/2008US7427592 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
09/23/2008US7427495 Enhancing or inhibiting apoptosis
09/23/2008CA2371393C Use of bismuth subgallate in inhibition of production of nitric oxide synthase
09/23/2008CA2350942C Iron-containing protein composition
09/23/2008CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
09/23/2008CA2332126C A novel human thrombopoietin mutein
09/23/2008CA2163256C Adenoviral vectors of animal origin and use thereof in gene therapy
09/23/2008CA2143125C Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
09/18/2008WO2008111300A1 Novel diamide derivative
09/18/2008WO2008111299A1 Novel diamide derivative
09/18/2008WO2008109976A1 Kunitz-type recombinant inhibitor
09/18/2008WO2008076437A3 Activin-actrii antagonists and uses for increasing red blood cell levels
09/18/2008WO2008069889A9 Methods of treating hemolytic anemia
09/18/2008WO2008048981A3 Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
09/18/2008WO2007090068A3 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
09/18/2008US20080227869 Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof
09/18/2008US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity